Table 1.
Baseline period | RRI period | Post-RRI period | |||
---|---|---|---|---|---|
Oct 2010–Jan 2011* | Apr–Jun 2011 | Jul–Sep 2011 | |||
N (%) | N (%) | Risk ratio (95% CI)+ | N (%) | Risk ratio (95% CI)+ | |
Maternal outcomes | |||||
HIV testing | 8591 | 9123 | 8068 | ||
HIVpositive | 1662 | 1890 | 1526 | ||
CD4 testing | 980/1662 (59.0%) | 1258/1890 (66.6%) | 1.1 (1.1-1.2)∧ | 966/1526 (63.3%) | 1.1 (1.0–1.1) |
HAART initiation | 228/1662 (13.7%) | 373/1890 (19.7%) | 1.4 (1.2–1.7)∧ | 331/1526 (21.7%) | 1.58 (1.4–1.8)∧ |
HIV-exposed infant outcomes | |||||
PCR testing | 768/1662 (46.2%) | 1149/1890 (60.8%) | 1.3 (1.2–1.4)∧ | 1327/1526 (87.0%) | 1.9 (1.8–2.0)∧ |
PCR positive | 93/768 (12.1%) | 158/1149 (13.8%) | 1.1 (0.9–1.4) | 152/1327 (11.5%) | 0.9 (0.7–1.2) |
HAART initiation | 51/93 (54.8%) | 95/158 (60.1%) | 1.1 (0.9–1.4) | 105/152 (69.0%) | 1.3 (1.0–1.6) |
Male partner engagement outcome | |||||
HIV testing | 660/8591 (7.7%) | 1496/9123 (16.3%) | 2.1 (2.0–2.3)∧ | 939/8068 (11.6%) | 1.5 (1.4–1.7)∧ |
*December 2010 data excluded.
+Results compared to baseline survey period.
∧Statistically significant.